Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-02-06, Stock:ABT, The news for the past five days is as follows:
2018-01-30: NEWS1: HCA Healthcare's (HCA) Q4 Earnings, Revenues Beat Estimates (Revised).NEWS2: HCA Healthcare's (HCA) Q4 Earnings, Revenues Beat Estimates (Revised).NEWS3: VTV, GE, AMGN, ABT: ETF Inflow Alert.NEWS4: VTV, GE, AMGN, ABT: ETF Inflow Alert.
2018-01-31: NEWS1: Developments in J&J’s Medical Device Business Could Drive Growth.NEWS2: Anthem (ANTM) Tops Q4 Earnings & Revenues, Issues '18 View.NEWS3: Anthem (ANTM) Tops Q4 Earnings & Revenues, Issues '18 View.NEWS4: See what the IHS Markit Score report has to say about Abbott Laboratories..
2018-02-01: NEWS1: Inside Abbott Laboratories’ 4Q17 Earnings Results: Key Highlights.NEWS2: Boston Scientific Tops Fourth-Quarter Sales Views, Earnings In Line.NEWS3: Boston Scientific Tops Fourth-Quarter Sales Views, Earnings In Line.NEWS4: Abbott Laboratories on the Street: Analyst Recommendations after the 4Q17 Results.NEWS5: Abbott Laboratories Traded at a 52-Week High after Posting Strong 4Q17 Results.NEWS6: ZBH’s 4Q17 Earnings Results Meet Analysts’ Estimates.NEWS7: Varian Medical Acquires Sirtex for $1.3 Billion: Highlights.NEWS8: ZBH’s 4Q17 Sales Exceed Sales Estimates.NEWS9: A Look at Johnson & Johnson’s 2018 Guidance.NEWS10: A Look at Analysts’ Estimates for Johnson & Johnson.NEWS11: How Does Wall Street View ZBH after Its 4Q17 Earnings Results?.NEWS12: Market Trends Toward New Normal in Alexander's, Atrion, FS, Gilead Sciences, Abbott Laboratories, and Johnson & Johnson — Emerging Consolidated Expectations, Analyst Ratings.NEWS13: J&J Accelerates Near-Term Goals in Medical Device Business.
2018-02-02: NEWS1: How Much Can Abbott's Stock Move In 2018?.NEWS2: How Much Can Abbott's Stock Move In 2018?.NEWS3: Novartis’s 4Q17 Revenues and Fiscal 2017 Revenues.NEWS4: Abbott Witnesses Stability in Its International Pediatric Nutrition Sales in 4Q17.NEWS5: How Tax Reform Affected Abbott’s 4Q17 Performance.NEWS6: Review of ZBH’s 2018 Operating Plan: What’s the Plan?.NEWS7: Wall Street Analysts’ Recommendations for JNJ in January 2018.NEWS8: These Developments Impacted Abbott Laboratories the Most in Fiscal 2017.
2018-02-05: NEWS1: Why Abbott Laboratories’ Product Pipeline Is Expected to Boost 2018.NEWS2: Why Abbott Laboratories Plans to Focus on Organic Growth in 2018.NEWS3: What’s ahead for Abbott Laboratories’ Medical Device Unit?.

Answer: Rise